Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98

Detalhes bibliográficos
Autor(a) principal: Critchley, I. A.
Data de Publicação: 2000
Outros Autores: Thornsberry, C., Piazza, G., Jones, M., Hickey, M. L., Barth, A. L., Mendes, C., Rossi, F. F., Sader, Helio Silva [UNIFESP], Teixeira, L. M., Sahm, D. F.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da UNIFESP
Texto Completo: http://dx.doi.org/10.1046/j.1469-0691.2000.00063.x
http://repositorio.unifesp.br/handle/11600/26275
Resumo: Objective To assess the susceptibility of the : key respiratory pathogens Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.Methods isolates were collected from five centers in Brazil during 1997-98, and susceptibility testing was conducted at a central laboratory according to National Committee for Clinical Laboratory Standards criteria.Results of the 359 Streptococcus pneumoniae isolates tested, 77% were susceptible, 19% were intermediate and 4% were resistant to penicillin. the susceptibility of S. pneumoniae to other beta-lactams and macrolides was greater than 90%, but cotrimoxazole was active against only 48% of the: isolates, the prevalence of susceptible isolates was 100.0% for vancomycin and 99.7% for levofloxacin. beta-Lactram, macrolide, and cotrimoxazole activities were negatively associated with penicillin resistance. of the 219 isolates of Haemophilus influenzae tested, 11% produced beta-lactamase and 11% were not susceptible to ampicillin. Nearly all H. influenzae isolates were susceptible to all other drugs, except cotrimoxazole (47% susceptibility). of the 52 Moraxella catarrhalis isolates, 98% produced beta-lactamase, and the MIC of all drugs was less than or equal to 4 mg/L, with the exception of amyicillin, where the: MIC90 was > 8 mg/L.Conclusions When these data are compared with previous reports, our findings suggest that the prevalence of pneumococci that are resistant to agents such as penicillin and cotrimoxazole may be increasing in Brazil, which highlights the need to continue surveillance programs.
id UFSP_b351860abc33274ca934f09340a90a90
oai_identifier_str oai:repositorio.unifesp.br/:11600/26275
network_acronym_str UFSP
network_name_str Repositório Institucional da UNIFESP
repository_id_str 3465
spelling Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98Streptococcus pneumoniaeantibiotic resistancesurveillanceObjective To assess the susceptibility of the : key respiratory pathogens Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.Methods isolates were collected from five centers in Brazil during 1997-98, and susceptibility testing was conducted at a central laboratory according to National Committee for Clinical Laboratory Standards criteria.Results of the 359 Streptococcus pneumoniae isolates tested, 77% were susceptible, 19% were intermediate and 4% were resistant to penicillin. the susceptibility of S. pneumoniae to other beta-lactams and macrolides was greater than 90%, but cotrimoxazole was active against only 48% of the: isolates, the prevalence of susceptible isolates was 100.0% for vancomycin and 99.7% for levofloxacin. beta-Lactram, macrolide, and cotrimoxazole activities were negatively associated with penicillin resistance. of the 219 isolates of Haemophilus influenzae tested, 11% produced beta-lactamase and 11% were not susceptible to ampicillin. Nearly all H. influenzae isolates were susceptible to all other drugs, except cotrimoxazole (47% susceptibility). of the 52 Moraxella catarrhalis isolates, 98% produced beta-lactamase, and the MIC of all drugs was less than or equal to 4 mg/L, with the exception of amyicillin, where the: MIC90 was > 8 mg/L.Conclusions When these data are compared with previous reports, our findings suggest that the prevalence of pneumococci that are resistant to agents such as penicillin and cotrimoxazole may be increasing in Brazil, which highlights the need to continue surveillance programs.MRL, Pharmaceut Serv, Herndon, VA 20171 USAMRL Pharmaceut Serv, Brentwood, TN USAMRL Pharmaceut Serv, Utrecht, NetherlandsHosp Clin Porto Alegre, Porto Alegre, RS, BrazilHosp Clin São Paulo, Lab Fleury, São Paulo, BrazilUniversidade Federal de São Paulo, São Paulo, BrazilUniv Fed Rio de Janeiro, Rio de Janeiro, BrazilUniversidade Federal de São Paulo, São Paulo, BrazilWeb of ScienceBlackwell Science LtdMRLMRL Pharmaceut ServHosp Clin Porto AlegreUniversidade de São Paulo (USP)Universidade Federal de São Paulo (UNIFESP)Universidade Federal do Rio de Janeiro (UFRJ)Critchley, I. A.Thornsberry, C.Piazza, G.Jones, M.Hickey, M. L.Barth, A. L.Mendes, C.Rossi, F. F.Sader, Helio Silva [UNIFESP]Teixeira, L. M.Sahm, D. F.2016-01-24T12:31:02Z2016-01-24T12:31:02Z2000-04-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersion178-184http://dx.doi.org/10.1046/j.1469-0691.2000.00063.xClinical Microbiology and Infection. Oxford: Blackwell Science Ltd, v. 6, n. 4, p. 178-184, 2000.10.1046/j.1469-0691.2000.00063.x1198-743Xhttp://repositorio.unifesp.br/handle/11600/26275WOS:000086961300002engClinical Microbiology and Infectioninfo:eu-repo/semantics/openAccessreponame:Repositório Institucional da UNIFESPinstname:Universidade Federal de São Paulo (UNIFESP)instacron:UNIFESP2016-01-24T10:31:02Zoai:repositorio.unifesp.br/:11600/26275Repositório InstitucionalPUBhttp://www.repositorio.unifesp.br/oai/requestbiblioteca.csp@unifesp.bropendoar:34652016-01-24T10:31:02Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)false
dc.title.none.fl_str_mv Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98
title Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98
spellingShingle Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98
Critchley, I. A.
Streptococcus pneumoniae
antibiotic resistance
surveillance
title_short Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98
title_full Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98
title_fullStr Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98
title_full_unstemmed Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98
title_sort Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98
author Critchley, I. A.
author_facet Critchley, I. A.
Thornsberry, C.
Piazza, G.
Jones, M.
Hickey, M. L.
Barth, A. L.
Mendes, C.
Rossi, F. F.
Sader, Helio Silva [UNIFESP]
Teixeira, L. M.
Sahm, D. F.
author_role author
author2 Thornsberry, C.
Piazza, G.
Jones, M.
Hickey, M. L.
Barth, A. L.
Mendes, C.
Rossi, F. F.
Sader, Helio Silva [UNIFESP]
Teixeira, L. M.
Sahm, D. F.
author2_role author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv MRL
MRL Pharmaceut Serv
Hosp Clin Porto Alegre
Universidade de São Paulo (USP)
Universidade Federal de São Paulo (UNIFESP)
Universidade Federal do Rio de Janeiro (UFRJ)
dc.contributor.author.fl_str_mv Critchley, I. A.
Thornsberry, C.
Piazza, G.
Jones, M.
Hickey, M. L.
Barth, A. L.
Mendes, C.
Rossi, F. F.
Sader, Helio Silva [UNIFESP]
Teixeira, L. M.
Sahm, D. F.
dc.subject.por.fl_str_mv Streptococcus pneumoniae
antibiotic resistance
surveillance
topic Streptococcus pneumoniae
antibiotic resistance
surveillance
description Objective To assess the susceptibility of the : key respiratory pathogens Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis to antimicrobial agents used to treat respiratory tract infections.Methods isolates were collected from five centers in Brazil during 1997-98, and susceptibility testing was conducted at a central laboratory according to National Committee for Clinical Laboratory Standards criteria.Results of the 359 Streptococcus pneumoniae isolates tested, 77% were susceptible, 19% were intermediate and 4% were resistant to penicillin. the susceptibility of S. pneumoniae to other beta-lactams and macrolides was greater than 90%, but cotrimoxazole was active against only 48% of the: isolates, the prevalence of susceptible isolates was 100.0% for vancomycin and 99.7% for levofloxacin. beta-Lactram, macrolide, and cotrimoxazole activities were negatively associated with penicillin resistance. of the 219 isolates of Haemophilus influenzae tested, 11% produced beta-lactamase and 11% were not susceptible to ampicillin. Nearly all H. influenzae isolates were susceptible to all other drugs, except cotrimoxazole (47% susceptibility). of the 52 Moraxella catarrhalis isolates, 98% produced beta-lactamase, and the MIC of all drugs was less than or equal to 4 mg/L, with the exception of amyicillin, where the: MIC90 was > 8 mg/L.Conclusions When these data are compared with previous reports, our findings suggest that the prevalence of pneumococci that are resistant to agents such as penicillin and cotrimoxazole may be increasing in Brazil, which highlights the need to continue surveillance programs.
publishDate 2000
dc.date.none.fl_str_mv 2000-04-01
2016-01-24T12:31:02Z
2016-01-24T12:31:02Z
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://dx.doi.org/10.1046/j.1469-0691.2000.00063.x
Clinical Microbiology and Infection. Oxford: Blackwell Science Ltd, v. 6, n. 4, p. 178-184, 2000.
10.1046/j.1469-0691.2000.00063.x
1198-743X
http://repositorio.unifesp.br/handle/11600/26275
WOS:000086961300002
url http://dx.doi.org/10.1046/j.1469-0691.2000.00063.x
http://repositorio.unifesp.br/handle/11600/26275
identifier_str_mv Clinical Microbiology and Infection. Oxford: Blackwell Science Ltd, v. 6, n. 4, p. 178-184, 2000.
10.1046/j.1469-0691.2000.00063.x
1198-743X
WOS:000086961300002
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv Clinical Microbiology and Infection
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 178-184
dc.publisher.none.fl_str_mv Blackwell Science Ltd
publisher.none.fl_str_mv Blackwell Science Ltd
dc.source.none.fl_str_mv reponame:Repositório Institucional da UNIFESP
instname:Universidade Federal de São Paulo (UNIFESP)
instacron:UNIFESP
instname_str Universidade Federal de São Paulo (UNIFESP)
instacron_str UNIFESP
institution UNIFESP
reponame_str Repositório Institucional da UNIFESP
collection Repositório Institucional da UNIFESP
repository.name.fl_str_mv Repositório Institucional da UNIFESP - Universidade Federal de São Paulo (UNIFESP)
repository.mail.fl_str_mv biblioteca.csp@unifesp.br
_version_ 1814268352046039040